Arginine methylation is a post-translational modification that plays pivotal roles in signal transduction and gene transcription during cell fate determination. We found protein methyltransferase 6 (PRMT6) to be frequently downregulated in hepatocellular carcinoma (HCC) and its expression to negatively correlate with aggressive cancer features in HCC patients. Silencing of PRMT6 promoted the tumor-initiating, metastasis, and therapy resistance potential of HCC cell lines and patient-derived organoids. Consistently, loss of PRMT6 expression aggravated liver tumorigenesis in a chemical-induced HCC PRMT6 knockout (PRMT6-/-) mouse model. Integrated transcriptome and protein-protein interaction studies revealed an enrichment of genes implicated in RAS signaling and showed that PRMT6 interacted with CRAF on arginine 100, which decreased its RAS binding potential and altered its downstream MEK/ERK signaling. Our work describes a critical repressive function for PRMT6 in maintenance of HCC cells by regulating RAS binding and MEK/ERK signaling via methylation of CRAF on arginine 100.
Pubmed ID: 30332648 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
Non-profit plasmid repository dedicated to helping scientists around the world share high-quality plasmids. Facilitates archiving and distributing DNA-based research reagents and associated data to scientists worldwide. Repository contains over 65,000 plasmids, including special collections on CRISPR, fluorescent proteins, and ready-to-use viral preparations. There is no cost for scientists to deposit plasmids, which saves time and money associated with shipping plasmids themselves. All plasmids are fully sequenced for validation and sequencing data is openly available. We handle the appropriate Material Transfer Agreements (MTA) with institutions, facilitating open exchange and offering intellectual property and liability protection for depositing scientists. Furthermore, we curate free educational resources for the scientific community including a blog, eBooks, video protocols, and detailed molecular biology resources.
View all literature mentionsThis monoclonal targets ERK1 + ERK2 (phospho T185 + Y187)
View all literature mentionsThis monoclonal targets Human SOX2
View all literature mentionsThis polyclonal targets PRMT6
View all literature mentionsThis unknown targets normal rabbit IgG
View all literature mentionsThis monoclonal targets beta-Actin
View all literature mentionsThis monoclonal targets Histone H3 antibody [mAbcam 24834]
View all literature mentionsThis monoclonal targets v-H-Ras
View all literature mentionsThis polyclonal targets MEK1/2
View all literature mentionsThis monoclonal targets Phospho-MEK1/2 (Ser217/221)
View all literature mentionsThis polyclonal targets p44/42 MAPK (Erk1/2)
View all literature mentionsThis polyclonal targets Erk1/2
View all literature mentionsThis monoclonal targets B-Raf
View all literature mentionsThis monoclonal targets c-Raf, phospho (Ser338)
View all literature mentionsThis monoclonal targets FLAG
View all literature mentionsThis polyclonal targets Histone H3, dimethyl (Arg2)
View all literature mentionsThis polyclonal targets sox2
View all literature mentionsThis monoclonal targets Di-Methyl Arginine
View all literature mentionsThis monoclonal targets CD133/1
View all literature mentionsThis polyclonal targets Prmt6
View all literature mentionsThis monoclonal targets CD90
View all literature mentionsThis monoclonal targets CD24
View all literature mentionsThis monoclonal targets CD133/2 (AC141)
View all literature mentions